Literature DB >> 9337805

Opportunistic fungal infections: superficial and systemic candidiasis.

S Hedderwick1, C A Kauffman.   

Abstract

Age alone is not usually sufficient for the development of disease due to Candida, but it appears to be associated with increased morbidity and mortality. Mucocutaneous Candida infections such as thrush and denture stomatitis are associated with local and mechanical factors. A rare and sight-threatening complication of cataract surgery is Candida endophthalmitis. Systemic Candida infections are becoming more common due to increasing use of immunosuppressive drugs and the increasing risk of nosocomial candidiasis in the intensive care unit. Candiduria is increasingly common in older patients with diabetes mellitus, indwelling urinary catheters, and a history of antibiotic therapy.

Entities:  

Mesh:

Year:  1997        PMID: 9337805

Source DB:  PubMed          Journal:  Geriatrics        ISSN: 0016-867X


  5 in total

1.  Modulation of endotoxin- and enterotoxin-induced cytokine release by in vivo treatment with beta-(1,6)-branched beta-(1,3)-glucan.

Authors:  J Soltys; M T Quinn
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

Review 2.  Treatment of systemic fungal infections in older patients: achieving optimal outcomes.

Authors:  C A Kauffman; S A Hedderwick
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

3.  Antifungal activities of origanum oil against Candida albicans.

Authors:  V Manohar; C Ingram; J Gray; N A Talpur; B W Echard; D Bagchi; H G Preuss
Journal:  Mol Cell Biochem       Date:  2001-12       Impact factor: 3.396

4.  The frequency of Candida species in onychomycosis.

Authors:  E Dorko; J Jautová; L Tkáciková; A Wantrubová
Journal:  Folia Microbiol (Praha)       Date:  2002       Impact factor: 2.099

5.  Efficacy and safety of caspofungin therapy in elderly patients with proven or suspected invasive fungal infections.

Authors:  M J Dinubile; K M Strohmaier; R J Lupinacci; A R Meibohm; C A Sable; N A Kartsonis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-03-07       Impact factor: 3.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.